Minimum Data Set (MDS) 3.0—The Basics:
CAAs / Scheduling

This module focuses on the triggers for a more thorough assessment—Care Area Assessments (CAA)—and the scheduling requirements under OBRA.

Your purchase entitles you to one year (365 days) of access, starting on the date of purchase.

To purchase the full 6-part training, click "Enroll in Training" and choose "Purchase All Six Basic Modules" on the payment screen. This option is available through any MDS Basic module.

Audience

This training is designed for long-term care professionals working with MDS 3.0 (nursing staff, MDS coordinators, social work, activities staff, therapy staff, nutrition and dietary staff) as well as facility administrators.

Learning Outcome

As a result of this activity, learners will expand their knowledge and competence on the CAA process and the scheduling requirements for OBRA assessments.

Objectives

By the end of this module you will be able to

  1. Summarize the revisions to Section S
  2. Identify the Care Area Assessment (CAAs)
  3. Describe the CAA process
  4. Develop care plans based on triggered CAAs
  5. Identify MDS assessments
  6. Describe scheduling requirements

Continuing Education Credits

CNE Credits offered until March 23, 2025.

The University at Albany School of Public Health is approved with distinction as a provider of nursing continuing professional development by the Northeast Multistate Division Education Unit, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

This offering is approved for 2.0 nursing contact hours.

The nursing contact hour(s) expire: 3/23/2025.

2.0 hours of Generic Continuing Education Credits.

Enroll in training

Enroll in the training using the learner's account. Enter the purchaser's information only in the payment step.

  • Training launched: January 10, 2019
    Last updated January 4, 2024
  • Estimated time: 2 hours

The planners, moderator, and presenters do not have any financial arrangements or affiliations with any ineligible companies whose products, research, or services may be discussed in this activity.

No commercial funding has been accepted for this activity.